New-onset pediatric idiopathic nephrotic syndrome secondary to COVID-19
- PMID: 36943466
- PMCID: PMC10028311
- DOI: 10.1007/s00467-023-05946-6
New-onset pediatric idiopathic nephrotic syndrome secondary to COVID-19
Conflict of interest statement
The authors declare no competing interests.
Comment on
-
COVID-19 and idiopathic nephrotic syndrome in children: systematic review of the literature and recommendations from a highly affected area.Pediatr Nephrol. 2022 Apr;37(4):757-764. doi: 10.1007/s00467-021-05330-2. Epub 2021 Oct 23. Pediatr Nephrol. 2022. PMID: 34687377 Free PMC article.
References
-
- Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 100 (Suppl 4):S1–S276. 10.1016/j.kint.2021.05.021 - PubMed
-
- Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Nigoghossian C, Ageno W, Madjid M, Guo Y, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75:2950–2973. doi: 10.1016/j.jacc.2020.04.031. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical